ArticlePediatric research2026
Emerging role of artificial intelligence in necrotizing enterocolitis and implementation challenges.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- cGAS-STING pathway regulated by spatiotemporal heterogeneity of tumor microenvironment and precision therapy strategies in lung cancer.Journal of experimental & clinical cancer research : CR · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Necrotizing enterocolitis (NEC) remains a persistent clinical challenge, with diagnostic strategies largely relying on reactive staging criteria that have not evolved significantly in decades. This commentary synthesizes emerging literature to evaluate the transformative potential of Artificial Intelligence (AI) and Machine Learning (ML) in shifting NEC management toward predictive precision. We review how ML algorithms are redefining risk stratification by integrating multimodal data. AI demonstrates superior utility in automating radiographic diagnosis, analyzing complex data to identify early disease progression, distinguishing medical from surgical phenotypes and providing objective support for difficult intervention decisions. Despite this promise, clinical translation is currently limited by data heterogeneity, small sample sizes, and the black box nature of complex algorithms. Further, the integration of AI methodologies into the clinical IT ecosystem requires careful planning, to assess how such tools affect clinical workflows, how performance changes over time, when they need to be retrained, changed, or shelved, e.g., ML operations (MLOps). We highlight that realizing AI's potential in the NICU requires a paradigm shift toward multicenter data sharing, the development of explainable AI models, and a rigorous ethical framework to ensure these tools augment rather than obscure clinical judgment. IMPACT: Traditional reliance on Bell's staging for NEC diagnosis is reactive and lacks the specificity required for early intervention. Artificial Intelligence and Machine Learning offer a transformative approach, demonstrating superior accuracy in risk stratification and surgical prediction by synthesizing complex, multimodal data that elude conventional clinical assessment. Future translational research must prioritize multicenter validation and algorithmic interpretability to safely integrate these predictive tools into real-time neonatal care.
Identifiers
42034914What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.